GSA CAPITAL PARTNERS LLP

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in AQST

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$483,641

-$865,555 QoQ

Shares Held

116,260

-51.8% QoQ

Ownership

0.093%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#58

of 184 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $11,914,926 across 21 Drug Manufacturers - Specialty & Generic names. AQST ranks #10 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	55,201	$2,264,897
2	ZTS	Zoetis Inc.	18,470	$1,327,254
3	IRWD	Ironwood Pharmaceuticals Inc	259,512	$1,092,545
4	BCRX	Biocryst Pharmaceuticals Inc	90,210	$902,100
5	LQDA	Liquidia Corp	10,098	$805,113
6	KNSA	Kiniksa Pharmaceuticals International, plc	11,219	$717,455
7	AMLX	Amylyx Pharmaceuticals, Inc.	39,241	$704,768
8	XERS	Xeris Biopharma Holdings, Inc.	82,830	$656,013

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$483,641	116,260	-51.8%	Shares	Sole	2026-08-06
2025-09-30	$1,349,196	241,359	+29.3%	Shares	Sole	2025-11-07
2025-06-30	$617,950	186,692	+36.1%	Shares	Sole	2025-07-22
2024-09-30	$683,011	137,151	+525.5%	Shares	Sole	2024-11-05
2024-06-30	$57,012	21,928	-78.3%	Shares	Sole	2024-08-15
2023-09-30	$154,306	100,854	+622.9%	Shares	Sole	2023-11-15
2023-06-30	$23,020	13,952	+1.8%	Shares	Sole	2023-08-14
2022-09-30	$16,033	13,704	-60.6%	Shares	Sole	2022-11-14
2022-03-31	$90,747	34,769	-64.4%	Shares	Sole	2022-05-11
2021-12-31	$380,449	97,802	-67.1%	Shares	Sole	2022-02-14
2021-09-30	$1,295,918	297,229	+203.9%	Shares	Sole	2021-11-12
2021-06-30	$388,269	97,801	-52.9%	Shares	Sole	2021-08-05
2021-03-31	$1,079,566	207,609	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.